There are opportunities for biotech investors to profit at each stage of clinical trials.
Tag:
pharmaceuticals
-
-
With its low payout ratio and booming free cash flow, this pet pharmacy is a dividend investor’s best friend.
-
Pfizer’s struggles with free cash flow and dividend cuts may have a silver lining if its growth meets expectations.